APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease.

Neurology
S CosentinoY Stern

Abstract

To determine whether APOE epsilon 4 predicts rate of cognitive change in incident and prevalent Alzheimer disease (AD). Individuals were recruited from two longitudinal cohort studies-the Washington Heights and Inwood Columbia Aging Project (WHICAP; population-based) and the Predictors Study (clinic-based)--and were followed for an average of 4 years. Three samples of participants diagnosed with AD, with diverse demographic characteristics and baseline cognitive functioning, were studied: 1) 199 (48%) of the incident WHICAP cases; 2) 215 (54%) of the prevalent WHICAP cases; and 3) 156 (71%) of the individuals diagnosed with AD in the Predictors Study. Generalized estimating equations were used to test whether rate of cognitive change, measured using a composite cognitive score in WHICAP and the Mini-Mental State Examination in Predictors, varied as a function of epsilon 4 status in each sample. The presence of at least one epsilon 4 allele was associated with faster cognitive decline in the incident population-based AD group (p = 0.01). Parallel results were produced for the two prevalent dementia samples only when adjusting for disease severity or excluding the most impaired participants from the analyses. APOE epsilon 4 may i...Continue Reading

Citations

Mar 11, 2009·Archives of Neurology·Elizabeth P HelznerYaakov Stern
Dec 17, 2011·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·V GaribottoD Perani
Sep 8, 2010·Molecular Psychiatry·V HeiseC E Mackay
Jan 9, 2013·Nature Reviews. Neurology·Chia-Chen LiuGuojun Bu
Feb 15, 2013·Applied Neuropsychology. Adult·Beyon H MiloyanJulia Chung
Jan 29, 2009·Molecular Neurodegeneration·Wei KongXudong Huang
Apr 28, 2012·Neurology·S BarralUNKNOWN National Institute on Aging Late-Onset Alzheimer's Disease Genetics Study
Nov 16, 2012·PloS One·Laurence O'DwyerHarald Hampel
Jul 5, 2013·PloS One·Christian GaserUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Jul 4, 2008·Pharmacogenomics·Meenal GuptaRitushree Kukreti
Jul 6, 2013·AJNR. American Journal of Neuroradiology·D HollandUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Jan 5, 2014·Acta Neuropathologica·Jon B ToledoUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Jul 8, 2014·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Christian SchmidtInga Zerr
Mar 14, 2013·Current Genetic Medicine Reports·Nilüfer Ertekin-TanerDavid A Bennett
Nov 10, 2011·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·B V P de-AlmadaF de-Paula
Sep 29, 2011·Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology·Jiong ShiSandra M Kuniyoshi
Mar 25, 2011·Dementia and Geriatric Cognitive Disorders·Stuart W S MacDonaldLars Bäckman
Mar 15, 2012·Dementia and Geriatric Cognitive Disorders·Christian SchmidtInga Zerr
Oct 15, 2008·Current Opinion in Psychiatry·Daniel M BlumbergerBenoit H Mulsant
Jan 16, 2014·International Review of Psychiatry·Alessandro SonaDavid Ames
Jul 16, 2010·Expert Review of Molecular Diagnostics·Thomas ZetzscheHarald Hampel
Apr 29, 2015·Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society·Young-Min LeeYoung-Hoon Kim
Dec 8, 2015·Journal of Alzheimer's Disease : JAD·Helen HochstetlerConstantine G Lyketsos
Jul 26, 2011·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Roberto GomeniMichael Gold
May 25, 2011·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·JoAnn T TschanzConstantine G Lyketsos
Nov 26, 2010·International Journal of Cardiology·Tuomas KerolaTuomo Nieminen
Sep 3, 2010·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Nikolaos ScarmeasYaakov Stern
Jun 12, 2010·Neurobiology of Aging·Liana G ApostolovaUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Sep 22, 2009·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Deniz Erten-LyonsJeffrey Kaye
May 20, 2015·Journal of Epidemiology·Shih-Chang HungHung-Chang Hung
Oct 11, 2014·Scientific Reports·Shan-May YongBoon-Seng Wong
Nov 13, 2009·Annals of the New York Academy of Sciences·Christiane Reitz, Richard Mayeux
Jun 17, 2008·Journal of Cellular and Molecular Medicine·Ignasi BarbaDavid Pozo
Sep 29, 2012·Proteomics·Juan DingJohn J Kopchick

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Genetics

Alzheimer's disease is a neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations with this feed.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.